INDV

Latest SEC Filings & News for INDV

2 most recent filings and news items mentioning INDV. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/INDV/news?limit=20"

Pull INDV filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Indivior reports Q2 2026 results and raises guidance

Indivior posted record quarterly net revenues and raised 2026 full-year guidance driven by strong SUBLOCADE performance. The company also announced a merger agreement with Supernus Pharmaceuticals.

View filing at SEC.gov →

Indivior Announces Merger with Supernus Pharmaceuticals

Indivior Pharmaceuticals, Inc. has entered into an agreement and plan of merger with Supernus Pharmaceuticals, Inc., marking a strategic acquisition to expand its product portfolio and market presence.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.